Balloon catheter method for reducing restenosis via irreversible electroporation

US10668208B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10668208-B2
Application numberUS-201815988408-A
CountryUS
Kind codeB2
Filing dateMay 24, 2018
Priority dateMar 27, 2008
Publication dateJun 2, 2020
Grant dateJun 2, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.

First claim

Opening claim text (preview).

That which is claimed is: 1. A balloon catheter device for insertion into a vessel and reducing neointima, comprising: a flexible elongated shaft comprising a distal end portion for insertion into a vessel; a balloon positioned at the distal end portion; a first electrode positioned at the distal end portion of the shaft, the first electrode being comprised of a conductive material which is flexible and generally conforms to an outer surface of the balloon during expansion of the balloon; a second electrode positioned at a point relative to the first electrode so as to allow electrical current to flow between the first and second electrodes and through vascular tissue to the first electrode, the second electrode being comprised of a conductive material which is flexible and conforms to the outer surface of the balloon during expansion of the balloon; wherein the first electrode and second electrode are positioned in an overlapping relationship on a single longitudinal axis to form a double helix spanning an entire length of the balloon, and comprising multiple helical turns around the balloon, and wherein the first and second electrodes are positioned to generate an electric field encompassing substantially the entire outer balloon surface; an electrical power source which provides electrical pulses to the electrodes for durations and in amounts sufficient to subject substantially all vascular cells in a target area of the vessel to non-thermal irreversible electroporation (NTIRE). 2. The device of claim 1 , wherein the first and second electrodes are formed from electrically conductive ink drawn on the balloon. 3. The device of claim 1 , wherein the device will carry out NTIRE using a voltage and a current with defined ranges over a defined period of time and in absence of drug being delivered into the vascular cells. 4. The device of claim 3 , wherein the electrical power source is designed to emit pulses wherein the pulses have a duration of from 50 to 200 microseconds. 5. The device of claim 1 , wherein the electrical power source applies current in pulses. 6. The device of claim 5 , wherein the electrical power source is configured to apply pulses having a duration of from 50 to 200 microseconds. 7. The device of claim 6 , wherein the electrical power source is configured to apply pulses of a current in a range of from 2,000 V/cm to 6,000 V/cm. 8. The device of claim 7 , wherein the electrical power source is configured to apply between two and twenty-five pulses. 9. The device of claim 8 , wherein the electrical power source is configured to apply 10 pulses for 100 microseconds each at a current of 3,800 V/cm.

Assignees

Inventors

Classifications

  • with a guide wire · CPC title

  • A61M5/14Primary

    Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor · CPC title

  • Irreversible electroporation · CPC title

  • Expandable means emitting energy, e.g. by elements carried thereon · CPC title

  • A61N1/327Primary

    for enhancing the absorption properties of tissue, e.g. by electroporation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10668208B2 cover?
Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversib…
Who is the assignee on this patent?
Univ California, Angiodynamics Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/14. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).